Insider Transactions in Q3 2021 at Avita Medical, Inc. (RCEL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2021
|
Suzanne Crowe |
BUY
Open market or private purchase
|
Direct |
1,066
+20.59%
|
$18,122
$17.08 P/Share
|
|
Sep 01
2021
|
Michael S Perry Director |
SELL
Open market or private sale
|
Direct |
11,220
-4.51%
|
$224,400
$20.68 P/Share
|
|
Sep 01
2021
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,754
+8.71%
|
-
|
|
Jul 06
2021
|
Michael Holder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jul 06
2021
|
Kathy M. Mc Gee Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jul 06
2021
|
Erin Liberto Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jul 06
2021
|
Andrew Quick Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
|
Jul 06
2021
|
Donna Shiroma General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+46.67%
|
-
|